U.S. Spatial Genomics And Transcriptomics Market Will Grow Rapidly In Coming Years

 U.S. Spatial Genomics And Transcriptomics Market Summary

The U.S. spatial genomics and transcriptomics market size was valued at USD 97.5 million in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030. Market expansion is primarily driven by the increasing recognition of its potential as a cancer diagnostic tool and the development of advanced in situ sequencing technologies. Additionally, rapid innovations in genomics, including human sequencing, tissue sequencing, and single-cell sequencing, have contributed to the emergence of spatial genomic sequencing, offering detailed spatial mapping of genetic information. These technological advancements, coupled with their clinical applications, are anticipated to significantly boost market growth.

The U.S. spatial genomics and transcriptomics market accounted for 38% of the global market share in 2023. The expansion is strongly influenced by several key factors, such as the rising demand for personalized medicine, the discovery of new biomarkers for diagnosis, and a surge in investments toward research and development. The increasing prevalence of chronic diseases, particularly cancer, is another crucial driver, creating demand for advanced diagnostics. For instance, in 2022, the U.S. recorded 1,918,030 new cancer cases and 609,360 cancer-related deaths. Furthermore, the increasing frequency of product launches, combined with strategic collaborations and investments in innovative technologies, continues to support market momentum.

Key Market Trends & Insights

  • The consumables product segment held the largest share of 53% in 2023. This dominance is largely attributed to high adoption rates, frequent utilization of reagents and kits, broad availability of consumable products, and the continuous procurement necessary for operating various analyzers. The consistent demand for consumables ensures recurring revenue streams, making it a critical growth driver within the market.
  • The spatial transcriptomics segment dominated the market with a 79% share in 2023 and is projected to grow at the fastest CAGR during the forecast period. The rapid growth of this segment is supported by the rising demand for nucleic acid sequencing of biological samples and single cells, as researchers increasingly adopt spatial transcriptomics for understanding gene expression in the context of tissue architecture.
  • The translational research segment accounted for 60% of revenue share in 2023. Its dominance stems from the growing application of spatial genomics in translating real-time tissue responses to external agents. The technology plays an essential role in translational research, particularly in areas such as cell mapping, neuroscience, and disease pathology, where detailed genetic and spatial information is crucial for developing targeted therapies.
  • The academic customer segment is projected to witness growth at a CAGR of 12% over the forecast period. This growth is supported by the increasing preference for spatial genomic analysis among academic and research institutions. The technology proves especially valuable for studying the morphological and genetic characteristics of cells involved in diseases such as cancer, diabetes, Alzheimer’s, and other genetic disorders, allowing deeper exploration into disease mechanisms.

Order a free sample PDF of the U.S. Spatial Genomics And Transcriptomics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2023 Market Size: USD 97.5 million
  • 2030 Projected Market Size: USD 222.2 million
  • CAGR (2024 - 2030): 12.7%

Key Companies & Market Share Insights

The dominant companies in the U.S. spatial genomics & transcriptomics market include 10X Genomics, Illumina, Inc., and Dovetail Genomics among others.

Companies are actively expanding their business presence through various strategies, including the acquisition of small or emerging companies, partnerships, and regional expansion to sustain their market dominance. This approach allows companies to strengthen their market position by integrating new businesses and leveraging their strengths to enhance their competitive edge on a scale.

Key Players

  • NanoString Technologies, Inc.
  • S2 Genomics, Inc.
  • Illumina, Inc.
  • Dovetail Genomics
  • 10x Genomics
  • Seven Bridges Genomics
  • Readcoor, Inc
  • Bio-Techne
  • Advanced Cell Diagnostics (ACD)

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. spatial genomics and transcriptomics market is set to experience significant growth due to advancements in sequencing technologies, rising cancer prevalence, and the increasing adoption of personalized medicine. The dominance of consumables, coupled with the fast-growing spatial transcriptomics segment, highlights the importance of recurring demand and innovation in driving expansion. Academic and translational research applications continue to broaden the scope of this technology, paving the way for deeper insights into disease pathology and therapeutic development. With growing R&D investments, product innovations, and academic collaborations, the market is positioned for robust growth and will play a pivotal role in shaping the future of precision medicine.

Comments

Post a Comment

Popular posts from this blog

Home And Laundry Care Industry Growth, Size, Share, Trends & Forecast

  Home And Laundry Care Industry The global  home and laundry care market  size is expected to reach USD 321.51 billion by 2030, registering a CAGR of 6.8% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growing population in developing economies such as Brazil, India, and China is boosting the demand for laundry and home care products. This market has noteworthy potential growth in the coming years owing to increasing awareness regarding the benefits of laundry and home care products such as hygiene and cleanliness products among consumers. Major market players are introducing innovative cleaners for laundry and homes in terms of quality, packaging, and fragrance. Similarly, they are launching eco-friendly cleaning products in the market. Also, they are introducing innovative cleaning infused with natural ingredients to advance the effectiveness of the product. For instance, in October 2021, Unilever South Africa launched a dishwashing liqui...
Read more

Asia Pacific Medical Device Cleaning Market Worth $8.12 Billion By 2028

Asia Pacific Medical Device Cleaning Industry Overview The Asia Pacific medical device cleaning market size was valued at USD 3.22 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028. The increasing prevalence of Hospital-acquired Infections (HAIs) coupled with the unprecedented surge in COVID-19 cases has fueled the demand for medical device cleaning products in the Asia Pacific (APAC) region. The rising prevalence of surgical site infections, the introduction of technologically advanced products, and growing government initiatives for spreading awareness about hygiene and cleanliness are a few more factors contributing to the market growth. Gather more insights about the market drivers, restrains and growth of the  Asia Pacific Medical Device Cleaning Market According to the Worldometer data, around 54,768,360 COVID-19 cases were reported in the Asia Pacific countries, on June 23 rd , 2021. Out of which, 1,829,004 were...
Read more

Healthcare Contract Development And Manufacturing Organization Market Worth $471.0 Billion By 2030

Healthcare Contract Development And Manufacturing Organization Industry Overview The global healthcare contract development and manufacturing organization market size was valued at USD 217.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.  An increase in uptake of outsourcing services by pharmaceutical companies and growth in R&D investments are expected to drive the market. Medical devices & pharmaceutical companies are outsourcing low-end services to reduce the overall cost of production. This trend is expected to contribute to the growth of the market for healthcare contract development and manufacturing organization (CDMO), in the forecast period. The presence of end-to-end service providers that offer value-added services for an integrated or risk-sharing business model is expected to bolster market growth. The COVID-19 pandemic has significantly impacted the global economy in 2020 and has had an ongoing i...
Read more